/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES/
MONTREAL, Nov. 6, 2013 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC
Group") (TSX: OMG) announces the completion of the amalgamation (the
"Amalgamation") of OPMEDIC Group and Kemourmedic Acquisition Inc., a
wholly-owned subsidiary of Kemourmedic Group Inc., all of the
outstanding shares of which are owned by Drs. Pierre St-Michel, Marc
Villeneuve and Jean-Yves Fontaine (collectively, the "Founders"),
pursuant to which OPMEDIC Group has been taken private.
Pursuant to the Amalgamation that closed earlier today, each shareholder
of OPMEDIC Group other than the Founders received one redeemable share
of the amalgamated corporation for each common share of OPMEDIC Group
held immediately prior to the Amalgamation and each redeemable share
was then immediately redeemed for $2.90 payable in cash.
Applications have been filed to delist the common shares of OPMEDIC
Group from the Toronto Stock Exchange and to terminate OPMEDIC Group's
status as a reporting issuer under applicable Canadian provincial
About OPMEDIC Group
OPMEDIC Group is a company incorporated under the laws of the Province
of Quebec which provides healthcare-related services including surgical
and endoscopic facilities and services to patients and surgeons (with
its OPMEDIC division), fertility treatments, medical imaging,
laboratory services and diagnostic procedures (with its PROCREA
Cliniques division, its subsidiary 8362556 Canada Inc. and a joint
venture 7667264 Canada Inc.) and sperm banking services (with its
PROCREA Cryopreservation Centre subsidiary).
The content of this press release has not been approved by nor submitted
to the TSX which assumes no liability therefor.
SOURCE: OPMEDIC GROUP INC.
For further information:
Vice President Finance and Chief Financial Officer
(514) 345-8535, x 2260